L
Liminatus Pharma, Inc. (LIMN)
NGM – Real vaqt narxi. Valyuta: USD
0.19
-0.01 (-6.59%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.20
+0.01 (3.92%)
Bozor oldidan: May 13, 2026, 9:03 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
0.19
-0.01 (-6.59%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.20
+0.01 (3.92%)
Bozor oldidan: May 13, 2026, 9:03 AM EDT
Liminatus Pharma, Inc., preclinical bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash usullarini ishlab chiqish bilan shug'ullanadi. U ilg'or qattiq o'smalar, shu jumladan mayda hujayrali o'pka saratonini davolash uchun I bosqich klinik sinovida bo'lgan insonlashtirilgan anti CD47 monoklonal antitelasi bo'lgan IBA101ni ishlab chiqadi. Kompaniya 2018 yilda tashkil etilgan va Kaliforniyaning Serritos shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Beom Kyu Choi | Chief Technology Officer & Member of Scientific Advisory Board |
| Dr. Byong Chul Yoo Ph.D. | Chief Science Officer & Member of Scientific Advisory Board |
| Dr. Sang-jin Lee Ph.D. | Head of Research & Development and Member of Scientific Advisory Board |
| Mr. Chris Kim J.D., L.L.M. | CEO & Chairman |
| Mr. Scott Dam | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-31 | 10-K | limn-20251231x10k.htm |
| 2026-03-04 | 8-K | tm267974d1_8k.htm |
| 2026-02-18 | 8-K | tm266571d1_8k.htm |
| 2026-02-11 | S-1 | limn-20250930xs1.htm |
| 2026-02-09 | 8-K | tm265593d1_8k.htm |
| 2026-01-26 | 8-K | tm264095d1_8k.htm |
| 2025-12-31 | DRS | filename1.htm |
| 2025-11-25 | 8-K | tm2532232d1_8k.htm |
| 2025-11-14 | 10-Q | limn-20250930x10q.htm |
| 2025-10-06 | 10-Q | limn-20250630x10q.htm |